Study protocol: Randomized controlled trial of web-based decision support tools for high-risk women and healthcare providers to increase breast cancer chemoprevention
Author:
Funder
National Cancer Institute
National Center for Advancing Translational Sciences, National Institutes of Health
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference99 articles.
1. Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study;Fisher;J. Natl. Cancer Inst.,1998
2. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial;Vogel;J. Am. Med. Assoc.,2006
3. Exemestane for breast-cancer prevention in postmenopausal women;Goss;N. Engl. J. Med.,2011
4. Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force;Nelson;Ann. Intern. Med.,2013
5. American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction;Visvanathan;J. Clin. Oncol.,2009
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial;Contemporary Clinical Trials;2024-07
2. A Mediation Analysis of Obesity and Adiponectin Association with Postmenopausal Breast Cancer Risk: A Nested Cohort Study in the International Breast Cancer Intervention Study II (IBIS-II) Prevention Trial;Nutrients;2024-06-30
3. Developing decision support tools for high-risk women and healthcare providers to increase chemoprevention informed choice and uptake: A retrospective translational science case study;Journal of Clinical and Translational Science;2024
4. Gynaecological Cancers in India: The Less Heard Perspectives of Healthcare Providers;International Journal of Environmental Research and Public Health;2023-01-26
5. Qualitative analysis of shared decision-making for chemoprevention in the primary care setting: provider-related barriers;BMC Medical Informatics and Decision Making;2022-08-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3